Fluarix GlaxoSmithKline - Treatment for Influenza Vaccination

Fluarix is indicated for adults 18 and older against influenza disease. This approval will help toward increasing flu vaccine supply in the United States for the 2005/2006 Flu Season.

Posted: August 2005

Related Articles:

Fluarix (influenza virus vaccine, inactivated) FDA Approval History

View comments

Hide
(web3)